摘要
药品专利期限补偿制度对于延长药品专利权人的专利保护期限、提高药品专利权人的市场预期效益具有明显的推动作用,但该制度将推迟仿制药进入市场的时间,对公民健康权益的保障而言可能产生弊端。我国实施药品专利期限补偿制度是一种必然选择,它既是激励本国药品技术创新的法律手段,也是参与国际药品谈判的重要条件。我国可以通过内部制约要素的完善和外部制约机制的调整,对药品专利期限补偿制度可能产生的弊端予以规避或消除,使该制度在我国充分发挥其应有功能。
The Drug Patent Term Extension System has a significant effect on extending the patent protection period of drug patentee and improving the market benefit of drug patentee.But the system will delay the entry of generic drugs into the market,which may have drawbacks for the protection of citizens'health rights.It is an inevitable choice for our country to implement the Drug Patent Term Extension System.It is not only the legal means to stimulate the innovation of national drug technology,but also an important condition to participate in the international drug negotiation.Through the improvement of the internal restriction elements and the adjustment of the external restriction mechanism,our country can avoid or eliminate the possible disadvantages of the Drug Patent Term Extension System,so that the system can give full play to its due function in our country.
作者
刘云开
LIU Yunkai(Center for Studies of Intellectual Property Rights,Zhongnan University of Economic and Law,Wuhan 430073)
出处
《中国发明与专利》
2020年第7期12-20,共9页
China Invention & Patent
基金
教育部、外国专家局“新时代知识产权学科创新引智基地”资助(Support by the 111 project),编号(B18058)。
关键词
药品专利
期限补偿
理论争议
中国选择
制约机制
drug patent
term compensation
theoretical dispute
china's choice
restriction mechanism
